Abbott Labs Splits In Bid To Drive Growth
Abbott Laboratories will split into two publicly traded companies that will respectively focus on research-based pharmaceuticals and diversified medical products, including generic drugs, to boost growth and stock returns, the company...To view the full article, register now.
Already a subscriber? Click here to view full article